$PCYN
PROCYON CORP Stock $pcyn

$pcyn Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000143774923032871 Filed on November 22, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$1.200M	$1.173M	$1.176M
YoY Change	1.36%	-0.22%	-1.2%
Cost Of Revenue	$263.3K	$260.7K	$294.9K
YoY Change	-10.27%	-11.6%	-10.16%
Gross Profit	$936.7K	$912.4K	$880.8K
YoY Change	5.19%	3.59%	2.21%
Gross Profit Margin	78.06%	77.78%	74.92%
Selling, General & Admin	$535.7K	$491.8K	$424.1K
YoY Change	12.92%	15.96%	19.0%
% of Gross Profit	57.18%	53.9%	48.15%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$20.88K	$19.15K	$10.91K
YoY Change	87.43%	75.52%	32.84%
% of Gross Profit	2.23%	2.1%	1.24%
Operating Expenses	$535.7K	$491.8K	$424.1K
YoY Change	12.92%	15.96%	19.0%
Operating Profit	-$101.4K	-$57.39K	-$11.45K
YoY Change	221.49%	401.1%	-117.38%
Interest Expense	$5.618K	$5.208K	$895.00
YoY Change	156.3%	481.9%	141.89%
% of Operating Profit
Other Income/Expense, Net	$13.98K	$14.17K	$895.00
YoY Change	177.6%	1482.79%	141.24%
Pretax Income	-$87.44K	-$43.23K	-$10.56K
YoY Change	229.83%	309.41%	-115.94%
Income Tax	$155.0K	-$9.370K	-$2.371K
% Of Pretax Income
Net Earnings	-$242.5K	-$33.86K	-$8.187K
YoY Change	1107.66%	313.52%	-119.27%
Net Earnings / Revenue	-20.21%	-2.89%	-0.7%
Basic Earnings Per Share	-$0.03	-$0.01	$0.00
Diluted Earnings Per Share	-$0.03	-$0.01	$0.00
COMMON SHARES
Basic Shares Outstanding	8.108M	8.087M	8.087M
Diluted Shares Outstanding	8.108M	8.108M	8.087M

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$838.8K	$969.1K	$865.8K
YoY Change	-5.35%	11.93%	-33.19%
Cash & Equivalents	$267.8K	$402.5K	$584.5K
Short-Term Investments	$570.9K	$566.6K	$281.3K
Other Short-Term Assets	$228.0K	$215.7K	$249.1K
YoY Change	-11.2%	-13.39%	-10.39%
Inventory	$530.9K	$544.3K	$775.9K
Prepaid Expenses
Receivables	$509.6K	$434.3K	$527.2K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$2.107M	$2.163M	$2.418M
YoY Change	-7.58%	-10.53%	-17.39%
LONG-TERM ASSETS
Property, Plant & Equipment	$301.3K	$315.3K	$149.8K
YoY Change	93.88%	110.47%	23.25%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$306.8K	$462.3K	$340.4K
YoY Change	-34.25%	35.79%	-6.18%
Total Long-Term Assets	$1.059M	$1.275M	$1.169M
YoY Change	-15.67%	9.11%	-12.81%
TOTAL ASSETS
Total Short-Term Assets	$2.107M	$2.163M	$2.418M
Total Long-Term Assets	$1.059M	$1.275M	$1.169M
Total Assets	$3.166M	$3.438M	$3.586M
YoY Change	-10.45%	-4.13%	-15.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$208.9K	$172.2K	$114.9K
YoY Change	58.99%	49.82%	-54.77%
Accrued Expenses	$374.2K	$396.2K	$362.6K
YoY Change	4.62%	9.27%	-24.25%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$583.1K	$568.4K	$477.5K
YoY Change	19.22%	19.02%	-34.83%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$230.6K	$275.4K	$449.1K
YoY Change	-43.29%	-38.68%	-26.84%
Total Long-Term Liabilities	$230.6K	$275.4K	$449.1K
YoY Change	-43.29%	-38.68%	-26.84%
TOTAL LIABILITIES
Total Short-Term Liabilities	$583.1K	$568.4K	$477.5K
Total Long-Term Liabilities	$230.6K	$275.4K	$449.1K
Total Liabilities	$813.7K	$843.8K	$926.7K
YoY Change	-9.16%	-8.94%	-31.19%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.266M	-$2.023M	-$1.947M
YoY Change	15.16%	3.9%	15.44%
Common Stock	$4.450M	$4.450M	$4.445M
YoY Change	0.12%	0.12%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.352M	$2.595M	$2.660M
YoY Change
Total Liabilities & Shareholders Equity	$3.166M	$3.438M	$3.586M
YoY Change	-10.45%	-4.13%	-15.95%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$242.5K	-$33.86K	-$8.187K
YoY Change	1107.66%	313.52%	-119.27%
Depreciation, Depletion And Amortization	$20.88K	$19.15K	$10.91K
YoY Change	87.43%	75.52%	32.84%
Cash From Operating Activities	-$126.6K	$4.585K	-$128.9K
YoY Change	-263.62%	-103.56%	-15.56%
INVESTING ACTIVITIES
Capital Expenditures	$8.130K	$53.41K	$7.003K
YoY Change	-51.49%	662.6%	-65.8%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$8.130K	-$53.41K	-$7.003K
YoY Change	-51.49%	662.6%	-65.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$0.00	-$40.00K
YoY Change		-100.0%	5.55%
NET CHANGE
Cash From Operating Activities	-126.6K	$4.585K	-$128.9K
Cash From Investing Activities	-8.130K	-$53.41K	-$7.003K
Cash From Financing Activities		$0.00	-$40.00K
Net Change In Cash	-134.7K	-$48.82K	-$175.9K
YoY Change	-764.81%	-72.25%	-16.65%
FREE CASH FLOW
Cash From Operating Activities	-$126.6K	$4.585K	-$128.9K
Capital Expenditures	$8.130K	$53.41K	$7.003K
Free Cash Flow	-$134.7K	-$48.82K	-$135.9K
YoY Change	-322.3%	-64.08%	-21.5%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-8187	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2371	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	260705	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	294904	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	912402	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	880799	usd
CY2023Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023Q3	dei	Amendment Flag AmendmentFlag	false
CY2023Q3	dei	Entity Central Index Key EntityCentralIndexKey	0000812306
CY2023Q3	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	478026	usd
CY2022Q3	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	468157	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	491767	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	424095	usd
CY2023Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	969793	usd
CY2022Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	892252	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-57391	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-11453	usd
CY2023Q3	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	8958	usd
CY2022Q3	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	0	usd
CY2023Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	5208	usd
CY2022Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	895	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	14166	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	895	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-43225	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10558	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9370	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2371	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-33855	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-8187	usd
CY2023Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	3633	usd
CY2022Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	4177	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-37488	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12364	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8108388
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8087388
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8108388
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8087388
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2617709	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	10721	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-33855	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	2594575	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	2667954	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-33855	usd
CY2023Q3	us-gaap	Depreciation Depreciation	19154	usd
CY2022Q3	us-gaap	Depreciation Depreciation	10913	usd
CY2023Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	6745	usd
CY2022Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2023Q3	pcyn	Operating Lease Right Of Use Asset Amortization Expense Reversal OperatingLeaseRightOfUseAssetAmortizationExpenseReversal	46686	usd
CY2022Q3	pcyn	Operating Lease Right Of Use Asset Amortization Expense Reversal OperatingLeaseRightOfUseAssetAmortizationExpenseReversal	44836	usd
CY2023Q3	pcyn	Accrued Interest On Certificates Of Deposit AccruedInterestOnCertificatesOfDeposit	4130	usd
CY2022Q3	pcyn	Accrued Interest On Certificates Of Deposit AccruedInterestOnCertificatesOfDeposit	173	usd
CY2023Q3	pcyn	Deferred Income Tax Expense Benefit Gross DeferredIncomeTaxExpenseBenefitGross	-9370	usd
CY2022Q3	pcyn	Deferred Income Tax Expense Benefit Gross DeferredIncomeTaxExpenseBenefitGross	29589	usd
CY2023Q3	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-0	usd
CY2022Q3	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	31960	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	10721	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-52942	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	120077	usd
CY2023Q3	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-4555	usd
CY2022Q3	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-1445	usd
CY2023Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	69410	usd
CY2022Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	13143	usd
CY2023Q3	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-82745	usd
CY2022Q3	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-125737	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2885	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-63161	usd
CY2023Q3	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-56593	usd
CY2022Q3	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-104714	usd
CY2023Q3	pcyn	Operating Lease Principal Payments OperatingLeasePrincipalPayments	42720	usd
CY2022Q3	pcyn	Operating Lease Principal Payments OperatingLeasePrincipalPayments	40003	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4585	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-168898	usd
CY2023Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	53405	usd
CY2022Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7003	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-53405	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7003	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-48820	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-175901	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	451306	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	760396	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	402486	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	584495	usd
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022Q3	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2022Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	25432
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11500
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.17
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2022Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	115000
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.17
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	25432
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.25
CY2023Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	140432
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.26
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	115000
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.17
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	140432
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.25
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	616717	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	576548	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	214611	usd
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	185370	usd
CY2023Q3	us-gaap	Inventory Gross InventoryGross	831328	usd
CY2023Q2	us-gaap	Inventory Gross InventoryGross	761918	usd
CY2023Q3	us-gaap	Inventory Noncurrent InventoryNoncurrent	287061	usd
CY2023Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	330513	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2023Q3	us-gaap	Share Price SharePrice	248
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0397	pure
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.9037	pure
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2023Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	787000	usd
CY2023Q3	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-7764	usd
CY2022Q3	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1965	usd
CY2023Q3	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1606	usd
CY2022Q3	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-406	usd
CY2023Q3	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-9370	usd
CY2022Q3	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-2371	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9370	usd
CY2023Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	199540	usd
CY2023Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6387	usd
CY2023Q3	pcyn	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	114237	usd
CY2023Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences	10271	usd
CY2023Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses	1465	usd
CY2023Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	5486	usd
CY2023Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	337386	usd
CY2023Q3	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	121779	usd
CY2023Q3	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	45057	usd
CY2023Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	166836	usd
CY2023Q3	pcyn	Deferred Tax Assets Liabilities Gross DeferredTaxAssetsLiabilitiesGross	170550	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	-0	usd
CY2023Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	170550	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	usd
CY2023Q3	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	0	usd
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.2535	pure
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.2535	pure
CY2023Q3	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	9077	usd
CY2022Q3	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	2217	usd
CY2023Q3	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1878	usd
CY2022Q3	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	459	usd
CY2023Q3	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-1539	usd
CY2022Q3	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-305	usd
CY2023Q3	pcyn	Effective Income Tax Rate Reconciliation Loss Carryforward Amount EffectiveIncomeTaxRateReconciliationLossCarryforwardAmount	46	usd
CY2022Q3	pcyn	Effective Income Tax Rate Reconciliation Loss Carryforward Amount EffectiveIncomeTaxRateReconciliationLossCarryforwardAmount	31960	usd
CY2023Q3	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	usd
CY2022Q3	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	31960	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9370	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2371	usd
CY2021Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	250000	usd
CY2023Q3	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	0	usd
CY2023Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	0	usd
CY2023Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	979744	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	499260	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	480484	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	979744	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	529017	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	450727	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	175317	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	275410	usd
CY2023Q3	us-gaap	Variable Lease Cost VariableLeaseCost	50567	usd
CY2022Q3	us-gaap	Variable Lease Cost VariableLeaseCost	50020	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y5M23D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0329	pure

Files In Submission

Name	View Source	Status
pcyn20230930_10q_htm.xml	Edgar Link	completed
0001437749-23-032871-index-headers.html	Edgar Link	pending
0001437749-23-032871-index.html	Edgar Link	pending
0001437749-23-032871.txt	Edgar Link	pending
0001437749-23-032871-xbrl.zip	Edgar Link	pending
ex_598654.htm	Edgar Link	pending
ex_598655.htm	Edgar Link	pending
ex_598656.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pcyn-20230930.xsd	Edgar Link	pending
pcyn20230930_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
pcyn-20230930_cal.xml	Edgar Link	unprocessable
pcyn-20230930_def.xml	Edgar Link	unprocessable
pcyn-20230930_lab.xml	Edgar Link	unprocessable
pcyn-20230930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCYN
PROCYON CORP Stock $pcyn

2023 Q4 Form 10-Q Financial Statement

#000143774923032871 Filed on November 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCYN PROCYON CORP Stock $pcyn

2023 Q4 Form 10-Q Financial Statement

#000143774923032871 Filed on November 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCYN
PROCYON CORP Stock $pcyn